PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,068,000 | +11.2% | 1,170,000 | 0.0% | 1.08% | +32.1% |
| Q4 2015 | $960,000 | -6.3% | 1,170,000 | +1.7% | 0.82% | +19.6% |
| Q3 2015 | $1,025,000 | +165.5% | 1,150,000 | +187.5% | 0.68% | +87.4% |
| Q2 2015 | $386,000 | +2.7% | 400,000 | +2.6% | 0.36% | +23.8% |
| Q1 2015 | $376,000 | -89.9% | 390,000 | 0.0% | 0.29% | -22.0% |
| Q4 2014 | $3,729,000 | +987.2% | 390,000 | +11.4% | 0.38% | -13.9% |
| Q3 2014 | $343,000 | -9.0% | 350,000 | +7.7% | 0.44% | +31.5% |
| Q2 2014 | $377,000 | – | 325,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|